Emerging data suggest this peptide, a dual agonist targeting both the gut-brain axis and glucose-dependent insulinotropic polypeptide , appears to offer a promising step forward for obesity treatment. https://bookmarkize.com/story21600558/a-retatrutide-peptide-peptide-the-advancement-in-weight-management